# US 8,278,442 B2 · Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,442 B2
- Document ID: US8278442B2
- Status: Granted
- Kind: B2
- Application number: 12/601,100
- Filed: 2008-05-22
- Published: 2010-07-08
- Granted: 2012-10-02
- Earliest claimed: 2007-05-22
- Assignees: Prosidion Limited
- Inventors: Jason Bloxham; Stuart Edward Bradley; Tom Banksia Dupree; Peter Timothy Fry; Patrick Eric Hanrahan; Thomas Martin Krulle; Martin James Procter; Colin Peter Sambrook-Smith; Karen Lesley Schofield; Donald Smyth; Alan John Stewart
- Web page: https://patentgrep.com/patent/US8278442B2

## CPC

- C07D 213/62: Oxygen or sulfur atoms
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/08: for nausea, cinetosis or vertigo; Antiemetics
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/06: Antihyperlipidemics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/24: Antidepressants
- A61P 25/30: for treating abuse or dependence
- A61P 25/32: Alcohol-abuse
- A61P 25/36: Opioid-abuse
- A61P 31/04: Antibacterial agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.

## Claims

### Claim 1

A compound of formula (I), or a pharmaceutically acceptable salt thereof:
wherein X and X1 are independently CH or N, provided that X and X1 are not both N, and wherein when X is CH the H may be replaced by the R4 group or where X1 is CH the H may be replaced by the R4 group or the —CONH2 substituent;
A is selected from:
wherein A is optionally substituted with one to three groups selected from nitrile, C1-C3 alkyl, C1-C3 alkoxy, halo, C1-C3 haloalkyl, C1-C3 haloalkoxy, —C(O)C1-C3 alkyl, C3-C8 cycloalkyl and —C1-C3 alkyl C3-C8 cycloalkyl;
R is hydrogen, C1-C6 alkyl or C2-C3 alkylOC1-C3 alkyl;
R1 is C1-C6 alkyl, C3-C6 alkenyl, —C1-C6 alkylaryl, C3-C10 cycloalkyl, —C1-C6 alkyl C3-C10 cycloalkyl, C3-C9 heterocyclyl, —C2-C6 alkyl-O—C3-C9 heterocyclyl, —C1-C6 alkyl C3-C9 heterocyclyl, —C2-C6 alkyl-O—C3-C10 cycloalkyl, —C2-C6 alkyl-O—C5-C10 heteroaryl, —C1-C6 alkyl C5-C10 heteroaryl, —C1-C6 alkylC(O)C1-C6 alkyl, —C1-C6 alkylC(O)C3-C9 heterocyclyl, —C1-C6 alkylC(O)aryl, —C2-C6 alkyl-O-aryl, —C2-C6 alkyl-O—C1-C6 alkyl, —C2-C6 alkylNR6R7, —(CH2)mC(O)NR6R7 and —(CH2)mNSO2R5; wherein each of the alkyl, alkenyl, cycloalkyl, heterocyclyl, heteroaryl and aryl groups are optionally substituted with one to three groups selected from halo, nitrile, C1-C6 haloalkyl, —S(O)n, C1-C6 alkyl, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, aryl, —C1-C6 alkylaryl, —C(O)C1-C6 alkyl, C1-C6 alkoxy, —O—C1-C6 haloalkyl and hydroxy;
or R and R1 may together with the N atom to which they are attached form a 4- to 7-membered heterocyclic ring optionally containing one further heteroatom selected from N, O and S, which ring may be substituted by one to five groups selected from NR8R9, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, aryl, hydroxy, halo, —C1-C6 alkylaryl, —C1-C6 alkoxy, —C1-C6 alkoxyaryl, aryloxy, —C(O)C1-C6 alkyl, oxo, C1-C6 haloalkyl and —O—(CH2)2—O—, wherein any aryl groups are optionally substituted with one to three halo groups;
R2 and R3 are independently hydrogen or C1-C3 alkyl;
R4 is hydrogen, C1-C3 alkyl, C1-C3 alkoxy, halo, C1-C3 haloalkyl, —C(O)C1-C3 alkyl, —C1-C3 alkyl C3-C8 cycloalkyl or C1-C3 haloalkoxy;
R5 is C1-C6 alkyl, —C1-C6 alkylaryl or —C1-C6 alkyl-O—C1-C6 alkyl;
R6 and R7 are independently hydrogen, C1-C6 alkyl, —C1-C6 alkylaryl, C3-C8 cycloalkyl, —C1-C6 alkyl C5-C10 heteroaryl, —C1-C6 alkyl C3-C7 heterocyclyl, —C1-C6 alkylC(O)C1-C6 alkyl, —C1-C6 alkylC(O)C3-C7 heterocyclyl, —C1-C6 alkylC(O)aryl, —C1-C6 alkyl-O-aryl, —C2-C6 alkyl-O—C1-C6 alkyl, —C1-C6 alkyl C3-C9 cycloalkyl; wherein each of the alkyl, cycloalkyl, heterocyclyl, heteroaryl and aryl groups are optionally substituted with one to three groups selected from halo, C1-C6 haloalkyl, —S(O)nC1-C6 alkyl, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, aryl, —C1-C6 alkylaryl, —C(O)C1-C6 alkyl, C1-C6 alkoxy and C1-C6 haloalkoxy;
or R6 and R7 may together with the N atom to which they are attached form a 4- to 7-membered heterocyclic ring optionally containing one further heteroatom selected from N, 0 and S, which ring may be substituted by one to three groups selected from NR8R9, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, aryl, hydroxy, halo, —C1-C6 alkylaryl, —C(O)C1-C6 alkyl, oxo and C1-C6 haloalkyl;
R8 and R9 are independently hydrogen or C1-C6 alkyl;
n is 0, 1, or 2; and
m is 1, 2 or 3;
provided that the —CONH2 substituent is not ortho to the —O— group on the phenyl or pyridyl ring.

### Claim 2 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein X1 is CH.

### Claim 3 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein A is selected from:

### Claim 4 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein the —CONH2 substituent is para to the —O-group on the phenyl or pyridyl ring.

### Claim 5 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein R is hydrogen or C1-C3 alkyl.

### Claim 6 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein R1 is C1-C6 alkyl, C1-C6 alkylaryl, C3-C10 cycloalkyl, C1-C6 alkyl C3-C10 cycloalkyl, C3-C7 heterocyclyl, C1-C6 alkyl C3-C7 heterocyclyl or C1-C6 alkyl C5-C10 heteroaryl; wherein each of the alkyl, cycloalkyl, heterocyclyl, heteroaryl and aryl groups are optionally substituted with one or two groups as described in claim 1.

### Claim 7 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein R and R1 together with the N atom to which they are attached form a 4- to 7-membered heterocyclic ring, which ring may be substituted by one to three groups selected from NR8R9, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, awl, hydroxy, halo, C1-C6 alkylaryl, C1-C6 alkoxy, C1-C6 alkoxyaryl, aryloxy, C(O)C1-C6 alkyl, oxo and C1-C6 haloalkyl, wherein any aryl groups are optionally substituted with one to three halo groups.

### Claim 8 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein R2 and R3 are hydrogen.

### Claim 9 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein R4 is hydrogen or fluoro.

### Claim 10 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein X is CH, N or CF.

### Claim 11

A compound of formula (I) selected from:
6-{4-[(2-Cyclopentylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[2-(Tetrahydropyran-4-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(3,3-Dimethylbutylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(3-Methylbutylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(4,4-Difluorocyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-trans-(4-tert-Butylcychexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[(2-Cyclohexlethyl)methylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-[4-(Isobutylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(Isopropylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(Phenethylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-(4-{[2-(2-Chlorophenyl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(2-Chlorobenzylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(2-Adamantan-2-ylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(4-Methoxycycohexylamino)methyl]naphthalene-1-yloxy}nicotinamide,
6-(4-{[2-(Tetrahydrofuran-2-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(Tetrahydropyran-4-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(2-Isopropoxyethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(2-Dimethylaminoethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(1-Methylpiperidin-4-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[1,5-Dimethyl-1H-pyrrol-2-ylmethyl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-[4-(Benzylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[(Cyclohexylmethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[(Tetrahydropyran-2-ylmethyl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-(4-{[(Tetrahydropyran-4-ylmethyl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-(4-{[2-(4-Methyl-piperidin-1-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-(4-{[2-(4-Methylpiperazin-1-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(cis-4-Isopropylcyclohexylamino)methyl]naplithalen-1-yloxy}nicotinamide,
6-{4-[(1-Oxaspiro-[4.4]non-3-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[(S)-(1-Oxaspiro[4.4]non-3-yl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-(4-{[(R)-(1-Oxaspiro[4.4]non-3-yl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-(4-[(1-Cyclopropylpiperidin-4-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[cis-(4-Methylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[trans-(4-Methylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[cis-(4-Phenylcychexylamino)methyl]napalen-1-yloxy}nicotinamide,
6-{4-[cis-(4-Propylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[cis-4-(1,1-Dimethylpropyl)cyclohexylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[trans-(4-Propylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[cis-(4-Phenylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(2-Hydroxy-2-phenylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[(1-Hydroxycyclohexylmethyl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-[4-(4-Methylpiperidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(4-Hydroxymethylpiperidin-1-ylmethy)naphthalen-1-yloxy]nicotinamide,
6-{-4-[(3-Piperidin-1-yl-propylamino)methyl]naphthalen-1-yloxyl}nicotinamide,
6-{4-[(4-Diethylaminocyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[1,4-Dioxa-8-aza-spiro[4.5]dec-8-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[2-Morpholin-4-ylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(1,2,2,6,6-Pentamethylpiperidin-4-ylamino)methyl]naphthalene-1-yloxy}nicotinamide,
6-(4-{[(5-Ethyl-1-aza-bicyclo[2.2.2]oct-2-ylmethyl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-[4-(1,3-Dihydroisoindol-2-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-(4-Piperidin-1-ylmethylnaphthalen-1-yloxy)nicotinamide,
6-{4-[((R)-2-Hydroxy-2-phenylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[(2-Cyclopentylethyl amino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-(Phenethylaminomethyl)naphthalen-1-yloxy}nicotinamide,
6-{5-[(Cyclohexylmethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[(2-Thiophen-2-ylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(5-Cyclohexylaminomethylnaphthalen-1-yloxy)nicotinamide
6-{5-[cis-(4-Propylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-[4-(4-Methylpiperazin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(4-Ethylpiperazin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[(3-Methylbutylamino)methyl]naphthalen-1-yloxy}nicotinonitrile,
6-[4-((S)-Indan-1-ylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-((R)-Indan-1-ylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[(5,6-Difluoroindan-2-ylamino) methyl]naphthalen-1-yloxy}nicotinamide,
6-[5-((R)-Indan-1-ylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-((S)-Indan-1-ylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-{5-[(3-Methylbutylamino)methyl]quinolin-8-yloxy}nicotinamide,
6-{5-[(2-Cyclohexylethylamino)methyl]quinolin-8-yloxy}nicotinamide,
6-{5-[cis-(4-tert-Butylcyclohexylamino)methyl]quinolin-8-yloxy}nicotinamide,
6-{5-[trans-(4-tert-Butylcyclohexylamino)methyl]quinolin-8-yloxy}nicotinamide,
6-{5-[(3,3-Dimethylbutylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[(2-Isopropoxyethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(5-{[2-(Tetrahydrofuran-2-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-(5-{[2-(Tetrahydropyran-4-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide
6-{5-[((R)-2-Hydroxy-2-ethenylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(5-{[2-(Tetrahydropyran-2-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{5-[(1-Oxaspiro-[4.4]non-3-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[((S)-2-Hydroxy-2-phenylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[(4,4-Dimethylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
3-Fluoro-4-(5-{[2-(tetrahydrofuran-4-yl)ethylamino]methyl}naphthalen-1-yloxy)benzamide,
3-Fluoro-4-(4-{[2-(tetrahydropyran-4-yl)ethylamino]methyl}naphthalen-1-yloxy)benzamide,
6-{4-[(3-Methylbutylamino)methyl]benzofuran-7-yloxy}nicotinamide,
6-{4-[(3-Methylbutylamino)methyl]benzo[b]thiophen-7-yloxy}nicotinamide,
6-[4-(4-Hydroxy-4-phenylpiperidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[(1-Isopropylpiperidin-4-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[((R)-2-Phenylpropylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[((R)-3-Trifluoromethylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-[4-((1R,2S,4S)-Bicyclo[2.2.1]hept-2-ylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[((1S,2S,3S,5R)-2,6,6-Trimethylbicyclo[3.1.1]hept-3-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
3-Fluoro-4-{4-[(3-methylbutylamino)methyl]naphthalen-1-yloxy}benzamide,
6-{5-[(3-Methylbutylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(5-{[Bis(3-methylbutyl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-[5-(Indan-2-ylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-{5-[(2-Cyclohexylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[trans-(4-tert-Butylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
4-{4-[(3-Methylbutylamino)methyl] isoquinolin-1-yloxy}benzamide,
4-{4-[(2-Cyclohexylethylamino)methyl]isoquinolin-1-yloxy}benzamide,
4-(4-{[2-(Tetrahydropyran-4-yl)ethylamino]methylisoquinolin-1-yloxy}benzamide,
6-{1-[(3-Methylbutylamino)methyl]isoquinolin-4-yloxy}nicotinamide,
6-{1-[(trans-4-Isopropylcyclohexylamino)methyl]isoquinolin-4-yloxy}nicotinamide,
6-{1-[(2-Cyclohexylethylamino)methyl]isoquinolin-4-yloxyl}nicotinamide,
6-[1-(Indan-2-ylaminomethyl)isoquinolin-4-yloxy]nicotinamide,
6-(5-{[(2,2-Dimethylcyclopropylmethyl)amino]methyl]naphthalene-1-yloxy}nicotinamide,
3-Fluoro-4-[1-(indan-2-ylaminomethyl)isoquinolin-4-yloxy]benzamide,
6-{4-[(2-Piperidin-1-yl-ethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[2-(2-Methylpiperidin-1-yl)ethylamino]methyl naphthalen-1-yloxy)nicotinamide,
6-(4-[2-(3-Methylpiperidin-1-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(2-Pyrrolidin-1-ylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[2-(Tetrahydropyran-2-yl)ethylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{5-[(4,4-Difluorocyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[(2-Cyclopropylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(5-{[cis-4-(1,1-Dimethylpropy)cyclohexylamino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(4-Trifluoromethylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[trans-(4-Isopropylcycloexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[(Tetrahydropyran-3-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(5-{[(-Hydroxycyclohexylmethyl)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(Tetrahydropyran-3-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[(2,2-Dimethylcyclopropylmethy)amino]methyl}naphthalen-1-yloxy)nicotinamide,
6-{4-[(2-Cyclopropylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(3-Hydroxy-3-methylbutylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(2-Cyclohexylethylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[(4,4-Dimethylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[trans-(4-Isopropylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-[4-(Indan-2-ylaminomethyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[(4-Hydroxycyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[trans-(4-Phenylcyclohexylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(4-{[trans-4-(1,1-Dimethylpropyl)cyclohexylamino]methyl}naphthalen-1-yloxy)-nicotinamide,
6-{5-[(5-Fluoroindan-2-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-(5-{trans-[4-(1,1-Dimethylpropyl)cyclohexylamino]methyl}naphthalen-1-yloxy)-nicotinamide,
6-{5-[(5-Fluoroindan-2-ylamino)methyl]naphthalen-1-yloxy}nicotinamide,
6-[4-({Methyl-[2-(tetrahydropyran-4-yl)ethyl]amino}methyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[(2-Cyclohexylethylamino)methyl]benzo[b]thiophen-7-yloxy}nicotinamide,
6-{4-[(2-Cyclohexylethylamino)methyl]benzofuran-7-yloxy}nicotinamide,
3-Chloro-4-{4-[(3-methylbutylamino)methyl]naphthalen-1-yloxy}benzamide,
4-{4-[(3-Methylbutylamino)methyl]naphthalene-1-yloxy}benzamide,
4-{8-[(3-Methylbutylamino)methyl]quinolin-4-yloxy}benzamide,
6-{4-[(3-Methylbutylamino)methyl]naphthalene-1-yloxy}pyridine-2-carboxamide,
2-{4-[(3-Methylbutylamino)methyl]naphthalen-1-yloxy}isonicotinamide,
6-[5-(4,4-Difluoropiperidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-(3-Methylazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-(4-Trifluoromethylpiperidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-(3-Fluoroazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-(3-Benzylazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-(5-Piperidin-1-ylmethylnaphthalen-1-yloxy)nicotinamide,
6-[5-(3-Methoxyazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-(5-Pyrrolidin-1-ylmethylnaphthalen-1-yloxy)nicotinamide,
6-[5-(3-Phenoxyazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-(4-Methylpiperidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-(3-Propoxyazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-{5-[3-(3-Fluorophenoxy)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[3-(4-Fluorophenoxy)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-[5-((S)-3-Methylpyrrolidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[5-((R)-3-Methylpyrrolidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(4,4-Difluoropiperidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(3-Methylazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(4-Trifluoromethylpiperidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide
6-[4-(3-Fluoroazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(3-Benzylazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(3-Methoxyazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-(4-Pyrrolidin-1-ylmethylnaphthalen-1-yloxy)nicotinamide,
6-[4-(3-Phenoxyazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-(3-Propoxyazetidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-{4-[3-(3-Fluorophenoxy)azetidin-1-ylmethyl]naphthalene-1-yloxy}nicotinamide,
6-{4-[3-(4-Fluorophenoxy)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-[4-((S)-3-Methylpyrrolidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-[4-((R)-3-Methylpyrrolidin-1-ylmethyl)naphthalen-1-yloxy]nicotinamide,
6-{5-[3-(2,4-Difluorobenzyl)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[3-(4-Fluorobenzyl)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-{5-[3-(3,4-Difluorobenzyl)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[3-(2,4-Difluorobenzyl)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide,
6-{4-[3-(4-Fluorobenzyl)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide, and
6-{4-[3-(3,4-Difluorobenzyl)azetidin-1-ylmethyl]naphthalen-1-yloxy}nicotinamide, or a
pharmaceutically acceptable salt of any one thereof.

### Claim 12 (depends on 1)

A pharmaceutical composition comprising a compound according to claim 1, or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
